Evidence map›Paper›PMID 35137080›Full record

ArticleGenome biology and evolution2022

Exploring the Natural Origins of SARS-CoV-2 in the Light of Recombination.

Spyros Lytras, Joseph Hughes, Darren Martin, Phillip Swanepoel, Arné de Klerk, Rentia Lourens, Sergei L Kosakovsky Pond, Wei Xia, Xiaowei Jiang, David L Robertson

Open access · goldAbstract read
In one paragraph

Article in Genome biology and evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 159 citations in OpenAlex.

  1. Novel AfricanJournal of virology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Hidden Markov models detect recombination and ancestry of SARS-CoV-2.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Spyros LytrasMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.ORCID 0000-0003-4202-6682
Joseph HughesMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.ORCID 0000-0003-2556-2563
Darren MartinComputational Biology Division, Department of Integrative Biomedical Sciences, University of Cape Town, South Africa.ORCID 0000-0002-8785-0870
Phillip SwanepoelComputational Biology Division, Department of Integrative Biomedical Sciences, University of Cape Town, South Africa.
Arné de KlerkComputational Biology Division, Department of Integrative Biomedical Sciences, University of Cape Town, South Africa.
Rentia LourensDivision of Neurosurgery, Department of Surgery, Neuroscience Institute, University of Cape Town, South Africa.
Sergei L Kosakovsky PondDepartment of Biology, Institute for Genomics and Evolutionary Medicine, Temple University, USA.
Wei XiaNational School of Agricultural Institution and Development, South China Agricultural University, Guangzhou, China.
Xiaowei JiangDepartment of Biological Sciences, Xi'an Jiaotong-Liverpool University (XJTLU), Suzhou, China.ORCID 0000-0002-6030-1249
David L RobertsonMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.ORCID 0000-0001-6338-0221
University of Cape Town · ZAMRC University of Glasgow Centre for Virus Research · GBEvolutionary Genomics (United States) · USSouth China Agricultural University · CNXi’an Jiaotong-Liverpool University · CN

Funding

Turning big data analysis infrastructure for HIV researchR01AI134384 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI NEKRUTENKO, ANTON, POND, SERGEI L KOSAKOVSKY · 2017 to 2021
$4.2M
Medical Research Council MC_PC_19026Medical Research Council MC_UU_12014/12Medical Research Council MC_UU_1201412NIAID NIH HHS R01 AI134384Wellcome TrustWellcome Trust 220977/Z/20/ZWellcome Trust 222574/Z/21/Z
6 · The paper itself

Abstract

The lack of an identifiable intermediate host species for the proximal animal ancestor of SARS-CoV-2, and the large geographical distance between Wuhan and where the closest evolutionary related coronaviruses circulating in horseshoe bats (members of the Sarbecovirus subgenus) have been identified, is fueling speculation on the natural origins of SARS-CoV-2. We performed a comprehensive phylogenetic study on SARS-CoV-2 and all the related bat and pangolin sarbecoviruses sampled so far. Determining the likely recombination events reveals a highly reticulate evolutionary history within this group of coronaviruses. Distribution of the inferred recombination events is nonrandom with evidence that Spike, the main target for humoral immunity, is beside a recombination hotspot likely driving antigenic shift events in the ancestry of bat sarbecoviruses. Coupled with the geographic ranges of their hosts and the sampling locations, across southern China, and into Southeast Asia, we confirm that horseshoe bats, Rhinolophus, are the likely reservoir species for the SARS-CoV-2 progenitor. By tracing the recombinant sequence patterns, we conclude that there has been relatively recent geographic movement and cocirculation of these viruses' ancestors, extending across their bat host ranges in China and Southeast Asia over the last 100 years. We confirm that a direct proximal ancestor to SARS-CoV-2 has not yet been sampled, since the closest known relatives collected in Yunnan shared a common ancestor with SARS-CoV-2 approximately 40 years ago. Our analysis highlights the need for dramatically more wildlife sampling to: 1) pinpoint the exact origins of SARS-CoV-2's animal progenitor, 2) the intermediate species that facilitated transmission from bats to humans (if there is one), and 3) survey the extent of the diversity in the related sarbecoviruses' phylogeny that present high risk for future spillovers.

Indexed as

PhylogenyRecombination, GeneticAnimalsChiropteraCoronavirusHumansPangolinsPhylogeographybatscoronavirusesCOVID-19host rangeoriginpangolinsrecombinationRhinolophusSarbecovirusesSARS-CoV-2

Identifiers

PMID35137080
PMCPMC8882382
OpenAlexW4210670259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.